File:Mainz.BioNTechSE.20200731.jpg · Wikimedia Commons · See Wikimedia Commons
BioNTech
Sign in to saveAlso known as Biopharmaceutical New Technologies, BioNTech SE, BioNTech AG, BNT, BNTX
BioNTech SE ( ; or short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
OverviewAI-generated
BioNTech SE, also known as Biopharmaceutical New Technologies, is an active company established in 2008. Headquartered in Mainz, Germany, the organization operates within the biological products industry. It is listed on the Nasdaq exchange under the ticker symbol BNTX.
The company employs 1,300 people and maintains a total asset value of 797,647,000. Its financial records indicate a total revenue of 127,575,000, alongside various net profit figures including -179,172,000, -47,662,000, and -85,950,000. Operating income has also varied, with recorded amounts of -181,518,000, -53,854,000, and -61,277,000.
Synthesized by Vinony from 38 facts across 6 sources: Wikidata, GLEIF, SEC EDGAR, ROR, Firecrawl, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company.name
- BioNTech SE
- Company.logo
- BioNTech logo.svg
- Company.image
- Mainz.BioNTechSE.20200731.jpg
- Company.image_caption
- Headquarters in Mainz
- Company.type
- Public company
- Company.industry
- Biotechnology
- Company.hq_location_city
- Mainz
- Company.hq_location_country
- Germany
- Company.num_locations
- 17
- Company.num_locations_year
- 2024
- Company.area_served
- Worldwide
- Company.products
- Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates
- Company.services
- Immunotherapy
- Company.revenue
- billion
- Company.revenue_year
- 2025
- Company.operating_income
- €−1.40 billion
- Company.income_year
- 2025
- Company.net_income
- €−1.14 billion
via Wikipedia infobox
Company
BNTX- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- 2M
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
- Jurisdiction
- DE
- Headquarters
- Mainz, DE
Research organization · ROR
- Type
- Company
- Founded
- 2008
- Location
- Mainz, Germany
- Also known as
- Biopharmaceutical New Technologies
- Status
- Active
GRID grid.434484.b · ISNI 0000 0004 4692 2203
Official website
BioNTech
BioNTech führt Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.
biontech.de →Link to the official site · 10,522 chars · not written by Vinony
~11 min read
Encyclopedic overview
18 sectionsContents
- History
- Foundation (2008–2014)
- Expansion, Series A financing (2015–2018)
- Series B financing and Nasdaq IPO (2019)
- COVID-19 (since 2020)
- Oncology and international expansion (since 2021)
- Company structure
- Locations
- Management Board
- Therapeutic areas
- Oncology
- Infectious diseases
- Criticism
- Influence by the Chinese government
- Pricing of the COVID vaccine
- See also
- References
- External links
BioNTech
Excerpted from Wikipedia’s “BioNTech” article, available under the CC BY-SA 4.0 licence.
Gallery (3)
On the map
14 mapped locations